Posts

Posted on

AMREP Reports Second Quarter Fiscal 2021 Results

PLYMOUTH MEETING, Pa., Dec. 08, 2020 (GLOBE NEWSWIRE) — AMREP Corporation (NYSE: AXR) today reported net income of $798,000, or $0.10 per share, for its 2021 fiscal second quarter ended October 31, 2020 compared to a net loss of $2,169,000, or $0.27 per share, for the same period of the prior year. For the first six months of 2021, AMREP had net income of $1,391,000, or $0.17 per share, compared to a net loss of $2,365,000, or $0.29 per share, for the same period of 2020. During the second quarter of 2020, AMREP recognized a non-cash pre-tax settlement charge of $2,929,000 due to AMREP’s defined benefit pension plan paying certain lump sum payouts of pension benefits to former employees.

AMREP Corporation, through its subsidiaries, is a major holder of land and leading developer of real estate in New Mexico.        

FINANCIAL HIGHLIGHTS

    Three Months Ended October 31,
      2020     2019  
         
Revenues   $     9,256,000   $ 3,960,000  
         
Net income (loss)   $       798,000   $ (2,169,000 )
         
Income (loss) per share – Basic and Diluted   $       0.10   $ (0.27 )
         
Weighted average number of common shares outstanding – basic     8,122,000     8,129,000  
Weighted average number of common shares outstanding – diluted     8,152,000     8,129,000  

    Six Months Ended October 31,
      2020     2019  
         
Revenues   $ 13,462,000   $ 8,727,000  
         
Net income (loss)   $     1,391,000   $ (2,365,000 )
         
Income (loss) per share – Basic and Diluted   $     0.17   $ (0.29 )
         
Weighted average number of common shares outstanding – basic     8,136,000     8,125,000  
Weighted average number of common shares outstanding – diluted     8,168,000     8,125,000  

AMREP Corporation’s financial statements on Form 10-Q are expected to be filed with the Securities and Exchange Commission concurrently with this release and will be available on AMREP’s website (www.amrepcorp.com/sec-filings/).

CONTACT:        
Adrienne M. Uleau
Vice President, Finance and Accounting
(610) 487-0907

 



Posted on

REVEREND MARKEL HUTCHINS APPOINTED TO NATIONAL LAW ENFORCEMENT MEMORIAL AND MUSEUM BOARD OF DIRECTORS

Washington, DC, Dec. 08, 2020 (GLOBE NEWSWIRE) —

December 8, 2020—(Washington, DC) The National Law Enforcement Officers Memorial Fund is pleased to announce the appointment of human and civil rights leader Reverend Markel Hutchins as a member of the Board of Directors. Rev. Hutchins is also President and Chief Executive Officer of MovementForward, Inc., and National Lead Organizer of the One Congregation One Precinct (OneCOP) initiative and National Faith & Blue Weekend.

“Rev. Markel’s commitment to law enforcement, his exceptional experience in faith-based leadership, and his hands-on commitment to uniting law enforcement and the community make for an exciting addition to the NLEOMF Board of Directors,” shares Marcia Ferranto, CEO of the National Law Enforcement Officers Memorial Fund. “Working together will no doubt help advance our mission in a very impactful way.”

The Reverend Markel Hutchins is the visionary behind the OneCOP initiative, as well as the National Faith & Blue Weekend that launched in the fall of 2020. From 1997 until 2006, Reverend Hutchins served the National Youth Connection, Inc. (NYC) as National President, CEO, and Chairman of the Board of its research and educational fund, the National Youth Challenge, Inc.  At the time, NYC was the nation’s only young adult led civil rights group.

Prior to founding MovementForward, the one-time congressional candidate was managing principal and CEO of MRH-LLC, a management and communications consulting firm that advised corporations, labor unions, small businesses and religious institutions on matters of diversity, public affairs, community relations and crisis management.

“Our pathway to progress around policing as a nation is a collaborative one that focuses on our commonalities rather than our differences,” shared Reverend Hutchins. “I am proud to serve an organization that is so uniquely positioned to build bridges of mutual trust, respect and understanding between law enforcement professionals and communities to facilitate justice and equal protection under the law.”

Established in 1984, the National Law Enforcement Officers Memorial Fund’s mission is to honor the fallen, make it safer for those who serve, and educate the public about the history of American law enforcement. The Memorial Fund oversees the National Law Enforcement Officers Memorial and the National Law Enforcement Museum, both located in Washington, DC.

For information on the National Law Enforcement Officers Memorial Fund, please visit LawMemorial.org.

For media inquiries, please contact Mary Petto at 202-737-7130.

– # # # –

About the National Law Enforcement Memorial and Museum

Established in 1984, the National Law Enforcement Officers Memorial Fund is a non-profit organization dedicated to telling the story of American law enforcement and making it safer for those who serve. The National Law Enforcement Officers Memorial contains the names of 22,217 officers who have died in the line of duty throughout U.S. history. For more information about the National Law Enforcement Officers Memorial, visit LawMemorial.org. Authorized by Congress in 2000, the 57,000-square-foot National Law Enforcement Museum at the Motorola Solutions Foundation Building tells the story of American law enforcement by providing visitors a “walk in the shoes” experience along with educational journeys, immersive exhibitions, and insightful programs. The Museum is an initiative of the National Law Enforcement Officers Memorial Fund, a 501(c)(3) organization. For more information on the Law Enforcement Museum, visit LawEnforcementMuseum.org.

Attachment


Mary Petto
National Law Enforcement Officers Memorial Fund
202-737-7130
[email protected]

Posted on

Saint Jean Carbon Inc. Settles With the ASC for Misleading Disclosure

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

OAKVILLE, Ontario, Dec. 08, 2020 (GLOBE NEWSWIRE) — Saint Jean Carbon Inc. (“Saint Jean” or the “Company”) (TSX-V: SJL) announces that the Alberta Securities Commission (the “ASC”) has concluded a Settlement Agreement with the Company, in connection with two news releases issued by the Company in February and March 2017. The shares of the Company are listed for trading under the symbol “SJL” on the TSX Venture Exchange.

In the Settlement Agreement, the Company admitted to misrepresentations in breach of Alberta securities laws by making misleading, untrue or incomplete statements in the two news releases. The Company acknowledged that these misrepresentations would reasonably be expected to have a significant effect on the market price or value of its securities.

The news releases announced that the Company had received its first order from Panasonic Corporation, as part of an offtake agreement, to supply graphite anode material to its manufacturing facility. In reality, the material supplied was a minimal sample order with nominal value, no offtake agreement had been executed by the parties and no commitment existed for Panasonic to take any amount of graphite at any time.

As part of the Settlement Agreement, the Company paid the ASC $62,500 and has undertaken that during the next four years all news releases will be authorized by at least two directors and officers of the Company.

The Company was a respondent in a Notice of Hearing issued by the ASC on June 19, 2020. The hearing into the allegation against the remaining respondent is scheduled to commence on December 14, 2020. For more information on the hearing, visit the Status of Current Proceedings page. A copy of the Settlement Agreement is also available on the ASC website at albertasecurities.com.

About Saint Jean

Saint Jean is a publicly traded carbon science company, with specific interests in energy storage and green energy creation and green re-creation, with holdings in graphite mining claims in the province of Quebec in Canada. For the latest information on Saint Jean’s properties and news please refer to the website: http://www.saintjeancarbon.com/

On behalf of the Board of Directors
Saint Jean Carbon Inc.
William Pfaffenberger, Chairman of the Board, Chief Executive Officer and President

Information Contact:

Email: [email protected]
Tel: (250) 381-6181

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


FORWARD LOOKING STATEMENTS:

This press release contains forward-looking statements, within the meaning of applicable securities legislation, concerning Saint Jean’s business and affairs.  In certain cases, forward-looking
statements can be identified by the use of words such as ‘‘plans’’, ‘‘expects’’ or ‘‘does not expect’’, “intends”, ‘‘budget’’, ‘‘scheduled’’, ‘‘estimates’’, “forecasts’’, ‘‘intends’’, ‘‘anticipates’’ or variations of such words and phrases or state that certain actions, events or results ‘‘may’’, ‘‘could’’, ‘‘would’’, ‘‘might’’ or ‘‘will be taken’’, ‘‘occur’’ or ‘‘be achieved’’. 

These forward-looking statements are based on current expectations, and are naturally subject to uncertainty and changes in circumstances that may cause actual results to differ materially. 

Although Saint Jean believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that these expectations will prove to be correct.

Statements of past performance should not be construed as an indication of future performance. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors, including those discussed above, could cause actual results to differ materially from the results discussed in the forward-looking statements. Any such forward-looking statements are expressly qualified in their entirety by this cautionary statement.

All of the forward-looking statements made in this press release are qualified by these cautionary statements.  Readers are cautioned not to place undue reliance on such forward-looking statements.  Forward-looking information is provided as of the date of this press release, and Saint Jean assumes no obligation to update or revise them to reflect new events or circumstances, except as may be required under applicable securities legislation.



Posted on

Megalith Financial Acquisition Corp. Transfers Listing to NYSE American LLC

NEW YORK, NY, Dec. 08, 2020 (GLOBE NEWSWIRE) — Megalith Financial Acquisition Corp. (the “Company” or “MFAC”) (NYSE: MFAC, MFAC.W, MFAC.U), a special purpose acquisition company, announced today that it will voluntarily delist from The New York Stock Exchange (“NYSE”) and simultaneously transfer to the NYSE American LLC (“NYSE American”), where the Company has been simultaneously approved for listing. The Company’s decision to voluntarily delist and transfer to the NYSE American was driven by a number of factors, including more favorable thresholds for continued listing on the NYSE American. Following the transfer, the Company will continue to file the same periodic reports and other information it currently files with the Securities and Exchange Commission (the “SEC”).  The Company anticipates the transfer to the NYSE American to occur on or about December 11, 2020.


About Megalith Financial Acquisition Corp.

Megalith Financial Acquisition Corp. is a blank check company incorporated in Delaware for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, with a focus on the fintech or financial services industries.  MFAC consummated its initial public offering on the NYSE in August 2018 and is listed under the symbol “MFAC.”  More information can be found on its website at http://www.megalithfinancial.com.     

Additional Information and Where to Find It

This communication is being made in respect of the proposed business combination between the Company and BankMobile Technologies, Inc., a Pennsylvania corporation (“BankMobile”) (the “Proposed Transaction”). The Company filed with the SEC a preliminary proxy statement on September 21, 2020 (the “Preliminary Proxy Statement”), a registration statement on Form S-4 (File No. 333-249815) on November 3, 2020, as amended on November 18, 2020 (the “Registration Statement”) (which includes the Preliminary Proxy Statement, as amended, and a prospectus (the “Prospectus”) in connection with the Proposed Transaction), and will file other documents regarding the Proposed Transaction with the SEC. After the SEC has concluded its comments with respect to the Registration Statement, the Company will mail the definitive proxy statement (the “Definitive Proxy Statement”) to its stockholders. Before making any voting or investment decision, investors and stockholders of the Company are urged to carefully read the Registration Statement, the Preliminary Proxy Statement and, when they become available, the final Prospectus, the Definitive Proxy Statement, and other relevant documents filed with the SEC, because such documents will contain important information about the Company, BankMobile and the Proposed Transaction. The Definitive Proxy Statement will be mailed to stockholders of the Company as of the record date established for voting on the Proposed Transaction. Stockholders will also be able to obtain copies of the final Prospectus and the Definitive Proxy Statement, without charge, once available, at the SEC’s website at www.sec.gov or by directing a request to: Megalith Financial Acquisition Corp., 535 Fifth Avenue, 29th Floor, New York, New York 10017.

Participants in the Solicitation

MFAC and its directors and executive officers may, under the rules of the SEC, be considered participants in the solicitation of proxies with respect to the Proposed Transaction described herein. Information about the directors and executive officers of MFAC and a description of their interests in the Company are contained in the Preliminary Proxy Statement and the Registration Statement filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

Non-Solicitation

The disclosure herein is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Proposed Transaction and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of MFAC, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a definitive document.
       
Forward Looking Statements

This release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Words such as “anticipate,” “estimate,” “expect,” “intend,” “plan,” and “project” and other similar words and expressions are intended to signify forward-looking statements.  Forward-looking statements are not guarantees of future results and conditions but rather are subject to various risks and uncertainties.  Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Investors are cautioned that there can be no assurance actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Please refer to the risks detailed from time to time in the reports we file with the SEC, including the Preliminary Proxy Statement, the Registration Statement, our Annual Report on Form 10-K for the year ended December 31, 2019, as well as other filings on Form 10-Q and periodic filings on Form 8-K, for additional factors that could cause actual results to differ materially from those stated or implied by such forward-looking statements. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.

Disclaimer

This release shall neither constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

Contact

A.J. Dunklau
Chief Executive Officer
[email protected]  



Posted on

Adam R. Rose Appointed to National Law Enforcement Memorial and Museum Board of Directors

Washington, DC, Dec. 08, 2020 (GLOBE NEWSWIRE) — December 8, 2020—(Washington, DC) The National Law Enforcement Officers Memorial Fund is pleased to announce the appointment of Adam R. Rose as a member of the Board of Directors. Earlier this year, Mr. Rose ended his 36-year career as a real estate developer at Rose Associates and is eager to expand his philanthropic interests and passion for uniting law enforcement and its citizens.     

“Adam has long been a significant contributor to the mission of the Memorial and will undoubtedly be an impactful addition to its governance,” shared Marcia Ferranto, CEO of the National Law Enforcement Officers Memorial Fund. “His experiences as a former law enforcement officer, as a board member of the New York City Police Foundation, and on the numerous nonprofit boards offer exceptional perspective for the future of our organization.

Mr. Rose has served on the board of numerous organizations including Jazz at Lincoln Center, The New York Botanical Garden, the New York Public Library, and Fairchild Tropical Botanic Garden. He is currently a trustee of the New York City Police Foundation and the FDNY Foundation.  His interest in law enforcement began with his service as an Auxiliary Trooper with the Connecticut State Police while he was obtaining his Bachelor of Arts from Yale College. He continued with summer sworn positions with two departments in Massachusetts. As the primary security director at Rose Associates, he also worked closely with the FBI, Secret Service, and NYPD.

“Any opportunity to assist law enforcement is one that I will prioritize over virtually anything else,” shared Adam Rose. “It gives me great pleasure to be able to add my efforts to help the National Law Enforcement Memorial and Museum grow and expand its effectiveness and reach.”

Established in 1984, the National Law Enforcement Officers Memorial Fund’s mission is to honor the fallen, make it safer for those who serve, and educate the public about the history of American law enforcement. The Memorial Fund oversees the National Law Enforcement Officers Memorial and the National Law Enforcement Museum, both located in Washington, DC.

For information on the National Law Enforcement Officers Memorial Fund, please visit LawMemorial.org.

For media inquiries, please contact Mary Petto at 202-737-7130.

– # # # –

About the National Law Enforcement Memorial and Museum

Established in 1984, the National Law Enforcement Officers Memorial Fund is a non-profit organization dedicated to telling the story of American law enforcement and making it safer for those who serve. The National Law Enforcement Officers Memorial contains the names of 22,217 officers who have died in the line of duty throughout U.S. history. For more information about the National Law Enforcement Officers Memorial, visit LawMemorial.org. Authorized by Congress in 2000, the 57,000-square-foot National Law Enforcement Museum at the Motorola Solutions Foundation Building tells the story of American law enforcement by providing visitors a “walk in the shoes” experience along with educational journeys, immersive exhibitions, and insightful programs. The Museum is an initiative of the National Law Enforcement Officers Memorial Fund, a 501(c)(3) organization. For more information on the Law Enforcement Museum, visit LawEnforcementMuseum.org.

Attachment 



Mary Petto
National Law Enforcement Officers Memorial Fund
202-737-7130
[email protected]

Posted on

Univar Solutions Expands Distribution Agreement with Solvay Novecare

PR Newswire

DOWNERS GROVE, Ill., Dec. 8, 2020 /PRNewswire/ — Univar Solutions Inc. (NYSE: UNVR) (“Univar Solutions” or “the Company”), a global chemical and ingredient distributor and provider of value-added services, announced today an expanded distribution agreement with Solvay Group’s Novecare Coatings and Industrial Process Solutions business units to distribute their coatings products in the United States and industrial products in the United States and Canada.

As the only national distributor for Solvay in the coatings and industrial businesses, Univar Solutions will leverage its reach, technical expertise and knowledge in these markets to broaden the availability of Solvay products across the United States and Canada. Novecare Coatings chemistries are used in everything from paints and adhesives to inks and waterborne and architectural coatings. Applications for the industrial product lines include lubricants and metalworking, metal cleaning and finishing, automotive, and chemical manufacturing.

“Through our network of solution centers, Univar Solutions is well positioned to deliver the functional, regulatory, and market trend insights needed to help expand business in these important markets. We are excited to be a distributor of Solvay’s Novecare business in the coatings and industrial markets in the United States and Canada and our breadth and depth of knowledge, experience, and broad market reach make us a strong partner for a world class manufacturer like Solvay,” commented Joshua Hicks, vice president of Industrial Solutions at Univar Solutions. “Not only does this agreement continue to strengthen our existing relationship, it also allows both of us to better serve these extremely dynamic market segments. Solvay has an excellent reputation in the market for producing high performance materials, and for continued innovation, quality, and application expertise that brings differential performance.”

Univar Solutions is currently Solvay’s largest distributor of surfactants and additives, including the Solvay Aerosol® line of specialty surfactants used in a wide variety of applications from emulsion polymer systems, to life science applications, and homecare products. As superwetters, the Solvay Aerosol® products provide excellent wetting characteristics and can help enable customers to achieve an improved cost of formulation without compromising performance.

“We look forward to working closely with Univar Solutions as part of our expanded agreement, helping their customers solve technical challenges and unlocking new business opportunities,” commented Chuck Price, vice president of coatings and industrial process solutions at Solvay. “With Univar Solutions sales and technical expertise and dedicated customer service, together, we are well positioned to help provide customers what they need to develop innovative products in coatings and a variety of industrial markets.”

About Univar Solutions
Univar Solutions (NYSE: UNVR) is a leading global specialty chemical and ingredient distributor representing a premier portfolio from the world’s leading producers. With the industry’s largest private transportation fleet and North American sales force, unparalleled logistics know-how, deep market and regulatory knowledge, world-class formulation and recipe development, and leading digital tools the company is well-positioned to offer tailored solutions and value-added services to a wide range of markets, industries, and applications. Univar Solutions is committed to helping customers and suppliers innovate and grow together. Learn more at univarsolutions.com.

About Solvay
Solvay is a science company whose technologies bring benefits to many aspects of daily life. With more than 24,100 employees in 64 countries, Solvay bonds people, ideas and elements to reinvent progress. The Group seeks to create sustainable shared value for all, notably through its Solvay One Planet plan crafted around three pillars: protecting the climate, preserving resources and fostering better life. The Group’s innovative solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices, health care applications, water and air purification systems. Founded in 1863, Solvay today ranks among the world’s top three companies for the vast majority of its activities and delivered net sales of €10.2 billion in 2019. Learn more at www.solvay.com.

Forward-Looking Statements
This press release includes certain statements relating to future events and our intentions, beliefs, expectations, and predictions for the future, which are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended.  Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company’s control. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the expectations and assumptions. A detailed discussion of these factors and uncertainties is contained in the Company’s filings with the Securities and Exchange Commission. Potential factors that could affect such forward-looking statements include, among others: the ultimate geographic spread of the COVID-19 pandemic; the duration and severity of the COVID-19 pandemic; actions that may be taken by governmental authorities to address or otherwise mitigate the impact of the COVID-19 pandemic; the potential negative impacts of COVID-19 on the global economy and our customers and suppliers; the overall impact of the COVID-19 pandemic on our business, results of operations and financial condition; other fluctuations in general economic conditions, particularly in industrial production and the demands of our customers; significant changes in the business strategies of producers or in the operations of our customers; increased competitive pressures, including as a result of competitor consolidation; significant changes in the pricing, demand and availability of chemicals; our levels of indebtedness, the restrictions imposed by our debt instruments, and our ability to obtain additional financing when needed; the broad spectrum of laws and regulations that we are subject to, including extensive environmental, health and safety laws and regulations; an inability to integrate the business and systems of companies we acquire, including of Nexeo Solutions, Inc., or to realize the anticipated benefits of such acquisitions; potential business disruptions and security breaches, including cybersecurity incidents; an inability to generate sufficient working capital; increases in transportation and fuel costs and changes in our relationship with third party providers; accidents, safety failures, environmental damage, product quality and liability issues and recalls; major or systemic delivery failures involving our distribution network or the products we carry; operational risks for which we may not be adequately insured; ongoing litigation and other legal and regulatory risks; challenges associated with international operations; exposure to interest rate and currency fluctuations; potential impairment of goodwill; liabilities associated with acquisitions, ventures and strategic investments; negative developments affecting our pension plans and multi-employer pensions; labor disruptions associated with the unionized portion of our workforce; and the other factors described in the Company’s filings with the Securities and Exchange Commission. We caution you that the forward-looking information presented in this press release is not a guarantee of future events or results, and that actual events or results may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “plan,” “seek, “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe” or “continue” or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise, except as required by law.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/univar-solutions-expands-distribution-agreement-with-solvay-novecare-301188840.html

SOURCE Univar Solutions Inc.

Posted on

CurrencyWorks Responds To OTC Markets Request On Recent Promotional Activity – Specifically With Respect to Penny Picks Promotional Material Distributed on December 3, 2020

Los Angeles, Dec. 08, 2020 (GLOBE NEWSWIRE) — CurrencyWorks Inc. (“CurrencyWorks” or the “Company”) (TSXV and OTCQB: CWRK), a publicly-traded company that builds and operates FinTech platforms for Digital Currencies, Security Tokens and Digital Assets that are designed to reduce operational costs, increase transactions plus liquidity and drives user engagement, announces that, at the request of OTC Market, it confirms that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity. The Company further confirms it was not aware of the promotional material that had been circulated by Penny Picks on December 3, 2020 until the OTC Markets brought it to the Company’s attention the same day.

In addition, the Company also confirms the following:

  • The Company is not aware of any promotional activities initiated by the Company, the management or its officer (s) and the Company is not in a position to comment on any effect on any third-party promotional material that is not under the Company’s control or direction.
    • However, the Company was made aware of a promotional material that was distributed by Penny Picks on December 3, 2020.
    • The Company was made aware of this promotional material by the OTC Markets on December 3, 2020 and at the specific request of the OTC Markets the Company is making this press release.
  • The Company or its officers (s) are not involved directly or indirectly, with the creation, distribution, or payment of any promotional materials.
  • Comments made in any promotion materials may not be completely true or accurate and should not be relied on. Company recommends to only use materials filed on EDGAR and any official Press Releases that the Company disseminates.
  • The Company after inquiring of its management, its officers, any controlling shareholders (defined as shareholders owning 10% or more of the Company’s securities), or any third-party service providers engaged and paid by the Company, now confirms that none of these groups have been involved in any way with the creation, distribution or payment of promotional materials related to the Company and its securities.
  • The Company confirms after inquiring with its management, its officers, directors and any controlling shareholders that none of them have sold or purchased the Company’s securities within the past 90 days.
  • The Company currently does not have any third-party providers engaged by the Company to provide investor relation services, public relation services, marketing or any other related services including promotional services of the Company or its securities over the past twelve months.
  • The Company has not at any point issued shares or convertible instruments allowing conversion to equity securities at prices constituting a discount to the current market rate at the time of the issuances.
    • However, the Company has the following convertible notes outstanding and balances as at September 30, 2020 are as follows: 1) Principle amount of $175,325 plus interest up to September 30, 2020 of $102,054 for a total of $277,379 at a conversion price of $0.03 per share and 2) Principle amount of $250,000 plus interest up to September 30, 2020 of $73,014 for a total of $323,014 at a conversion price of $0.10 per share.

About CurrencyWorks

CurrencyWorks Inc. (TSX: CWRK and OTCQB: CWRK) is a publicly-traded company that builds and operates FinTech platforms for Digital Currencies, Security Tokens and Digital Assets that are designed to reduce operational costs, increase transactions plus liquidity and drives user engagement.

For more information on CurrencyWorks, please visit us at: www.currencyworks.io. For additional investor info visit www.currencyworks.io or www.sedar.com and www.sec.gov searching CWRK.

Media Contact

Arian Hopkins
[email protected]

Company Contact
Bruce Elliott, President
Phone: 424-570-9446
[email protected]

Investor Inquiries
Phone: 424-570-9446 ext. 8
[email protected]

N
either TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Posted on

U.S. Silicon Metal Producers Welcome Duties on Unfairly-Traded Silicon Metal Imports from Bosnia and Herzegovina, Iceland

PR Newswire

WASHINGTON, Dec. 8, 2020 /PRNewswire/ — American manufacturers Globe Specialty Metals, Inc., a subsidiary of Ferroglobe PLC (NASDAQ:GSM) (“GSM”), and Mississippi Silicon LLC (“MS”), together representing the majority of American silicon metal production, today welcomed news that the U.S. Department of Commerce (“Commerce”) will impose preliminary duties of up to 47.54% on all silicon metal imports from Iceland and from Bosnia and Herzegovina.

Today’s announcement is the latest development in ongoing investigations of unfairly-traded silicon metal imports from Bosnia and Herzegovina, Iceland, Malaysia and Kazakhstan and closely follows an announcement that Commerce will impose preliminary duties up to 120% on all silicon metal import from Kazakhstan. In August, the U.S. International Trade Commission (ITC) preliminarily determined that imports from all four countries are a cause of material injury to the U.S. industry.

“The Commerce Department’s action to address unfairly-traded imports from Bosnia and Herzegovina and Iceland come as good news to our business, our workers, and our entire industry,” said Eddie Boardwine, Chief Operations Officer of MS. “We greatly appreciate the government’s efforts to stop unfair trade practices and look forward to seeing conditions in the U.S. market reflect free and fair trade of silicon metal.”

On June 30, 2020, GSM and MS filed petitions to stop silicon metal producers in Bosnia and Herzegovina, Iceland, Malaysia and Kazakhstan from selling dumped and unfairly subsidized silicon metal imports into the United States. In their petitions, the companies asked the Commerce and ITC to impose duties on to offset unfair pricing and unfair subsidies.

“The fact that suppliers in Bosnia and Herzegovina and Iceland have tilted the playing field has made it really difficult for us to even compete,” said Marco Levi, Chief Executive Officer of GSM’s parent, Ferroglobe. “Like the duties recently imposed on imports from Kazakhstan, these duties will level the playing field and restore real, honest competition. We appreciate the diligent efforts by the Commerce Department to see that our trade rules are followed.”

Following today’s announcement, preliminary determinations will be announced in the Malaysia investigation on January 27, 2021. 

Silicon metal is an important element added to various grades of aluminum alloys used in performance applications such as automotive components and aerospace products. Silicon metal also is a critical raw material in the production of silicone compounds used in numerous products including sealants, adhesives, rubber gaskets, caulking compounds, lubricants, food additives, coatings, polishes, and cosmetics, among others. In addition, silicon metal is the base material in the production of polysilicon, a purified form of silicon used in solar cells and semi-conductors.

For more on the petitions, see the companies’ press release.

For more on the ITC’s investigation, see the Commission’s press release.

For more on Commerce’s investigations, see the agency’s press release.

For more on Commerce’s preliminary determination in the Kazakhstan investigation, see Globe’s and Mississippi Silicon’s press release.

About GSM and MS

Globe Specialty Metals, Inc. is a wholly-owned U.S. subsidiary of Ferroglobe PLC, one of the world’s leading suppliers of silicon metal, silicon- and manganese- based specialty alloys and ferroalloys, serving a customer base across the globe in dynamic and fast-growing end markets, such as solar, automotive, consumer products, construction and energy. Through its subsidiaries, GSM owns metallurgical manufacturing facilities and other operations in Ohio, West Virginia, New York, Alabama, Indiana, Florida and Kentucky.

Mississippi Silicon LLC is a partnership between Rima Holding USA, Inc. and Clean Tech I LLC. Rima Holding USA Inc. is the majority owner of MS and also is associated with Rima Industrial S/A, a leading ferroalloy and non-ferrous metals producer in Brazil. Clean Tech I LLC is a partnership composed of strategic investors and financial advisers. MS’s manufacturing operation is based in Burnsville, MS, and its silicon metal serves customers throughout the United States.

Globe and Mississippi Silicon are represented in these proceedings by Adam H. Gordon, Esq. of The Bristol Group PLLC.

For more information, visit http://investor.ferroglobe.com and https://www.missilicon.com/.

Contact Elizabeth Heaton, [email protected], 202-445-9858.

Cision View original content:http://www.prnewswire.com/news-releases/us-silicon-metal-producers-welcome-duties-on-unfairly-traded-silicon-metal-imports-from-bosnia-and-herzegovina-iceland-301188854.html

SOURCE Globe Specialty Metals / Mississippi Silicon

Posted on

Syros Closes $90.5 Million Strategic Financing

Syros Closes $90.5 Million Strategic Financing

CAMBRIDGE, Mass.–(BUSINESS WIRE)–
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, announced today that it has closed a previously announced private financing with a group of institutional accredited investors led by Bain Capital Life Sciences, with participation from new and existing investors, including Ally Bridge Group, Omega Funds, OrbiMed Advisors, EcoR1 Capital, and Samsara BioCapital.

In this financing, Syros sold an aggregate of 10,312,500 shares of its common stock and pre-funded warrants (Pre-Funded Warrants) to purchase an aggregate of 1,000,000 shares of common stock, and accompanying warrants (Warrants) to purchase an aggregate of up to 2,828,125 additional shares of common stock (or Pre-Funded Warrants in lieu thereof) at a price of $8.00 per share and accompanying Warrant (or $7.99 per Pre-Funded Warrant and accompanying Warrant). The price per Pre-Funded Warrant and accompanying Warrant represents the price of $8.00 per share and accompanying Warrant to be sold in the private placement, minus the $0.01 per share exercise price of each such Pre-Funded Warrant. The exercise price of the Warrants is $11.00 per share, or if exercised for a Pre-Funded Warrant in lieu thereof, $10.99 per Pre-Funded Warrant (representing the Warrant exercise price of $11.00 per share minus the $0.01 per share exercise price of each such Pre-Funded Warrant). The Warrants are exercisable at any time during the period beginning on June 8, 2021 and ending on December 8, 2025. The Pre-Funded Warrants are exercisable at any time after their original issuance and will not expire. The gross proceeds from the sales of common stock and Pre-Funded Warrants are $90.5 million, before deducting offering expenses.

Net proceeds from this financing are expected to be used to advance Syros’ clinical development pipeline, business development activities, working capital and other general corporate purposes.

The securities sold in the private placement have not been registered under the Securities Act of 1933, as amended (Securities Act), or any state or other applicable jurisdiction’s securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions’ securities laws. The Company has agreed to file a registration statement with the U.S. Securities and Exchange Commission registering the resale of the shares of common stock issued and sold in the private placement no later than the 30th day after the closing of the offering. Any offering of the securities under the resale registration statement will only be by means of a prospectus.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Syros Pharmaceuticals

Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to develop medicines that provide a profound benefit for patients with diseases that have eluded other genomics-based approaches. Syros is advancing a robust clinical-stage pipeline, including SY-1425, a first-in-class oral selective RARα agonist in RARA-positive patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia, SY-2101, a novel oral form of arsenic trioxide in patients with acute promyelocytic leukemia, and SY-5609, a highly selective and potent oral CDK7 inhibitor in patients with select solid tumors. Syros also has multiple preclinical and discovery programs in oncology and monogenic diseases. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, including without limitation statements regarding the use of proceeds from the private placement and the net proceeds from the private placement. The words ‘‘anticipate,’’ ‘‘believe,’’ ‘‘continue,’’ ‘‘could,’’ ‘‘estimate,’’ ‘‘expect,’’ “hope,” ‘‘intend,’’ ‘‘may,’’ ‘‘plan,’’ ‘‘potential,’’ ‘‘predict,’’ ‘‘project,’’ ‘‘target,’’ ‘‘should,’’ ‘‘would,’’ and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements as a result of various important factors, including Syros’ ability to: advance the development of its programs under the timelines it projects in current and future clinical trials; demonstrate in any current and future clinical trials the requisite safety, efficacy and combinability of its drug candidates; sustain the response rates and durability of response seen to date with its drug candidates; successfully develop a companion diagnostic test to identify patients with the RARA biomarker; obtain and maintain patent protection for its drug candidates and the freedom to operate under third party intellectual property; obtain and maintain necessary regulatory approvals; identify, enter into and maintain collaboration agreements with third parties; manage competition; manage expenses; raise the substantial additional capital needed to achieve its business objectives; attract and retain qualified personnel; and successfully execute on its business strategies; complete the closing for the private placement; risks described under the caption “Risk Factors” in Syros’ Annual Report on Form 10-K for the year ended December 31, 2019 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, each of which is on file with the Securities and Exchange Commission; and risks described in other filings that Syros makes with the Securities and Exchange Commission in the future. In addition, the extent to which the COVID-19 outbreak continues to impact Syros’ workforce and its clinical trial operations activities, and the operations of the third parties on which Syros relies, will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, additional or modified government actions, and the actions that may be required to contain the virus or treat its impact. Any forward-looking statements contained in this press release speak only as of the date hereof, and Syros expressly disclaims any obligation to update any forward-looking statements, whether because of new information, future events or otherwise.

Media Contact:

Naomi Aoki

Syros Pharmaceuticals

617-283-4298

[email protected]

Investor Contact:

Hannah Deresiewicz

Stern Investor Relations, Inc.

212-362-1200

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Oncology Health Genetics Clinical Trials Pharmaceutical Biotechnology

MEDIA:

Logo
Logo
Posted on

The TJX Companies, Inc. Announces 13% Increase in Its Quarterly Common Stock Dividend

The TJX Companies, Inc. Announces 13% Increase in Its Quarterly Common Stock Dividend

FRAMINGHAM, Mass.–(BUSINESS WIRE)–
The TJX Companies, Inc. (NYSE:TJX) today announced the declaration of a quarterly dividend on its common stock of $.26 per share payable March 4, 2021, to shareholders of record on February 11, 2021. This represents a 13% increase in the per share dividend compared to the Company’s previous dividend paid in March 2020.

About The TJX Companies, Inc.

The TJX Companies, Inc. is the leading off-price retailer of apparel and home fashions in the U.S. and worldwide. As of October 31, 2020, the end of the Company’s third quarter, the Company operated a total of 4,574 stores in nine countries, the United States, Canada, the United Kingdom, Ireland, Germany, Poland, Austria, the Netherlands, and Australia, and four e-commerce sites. These include 1,272 T.J. Maxx, 1,134 Marshalls, 821 HomeGoods, 48 Sierra, and 34 Homesense stores, as well as tjmaxx.com, marshalls.com, and sierra.com in the United States; 280 Winners, 143 HomeSense, and 102 Marshalls stores in Canada; 602 T.K. Maxx and 78 Homesense stores, as well as tkmaxx.com, in Europe; and 60 T.K. Maxx stores in Australia. TJX’s press releases and financial information are available at TJX.com.

Important Information at Website

The Company routinely posts information that may be important to investors in the Investors section at TJX.com. The Company encourages investors to consult that section of its website regularly.

The TJX Companies, Inc.

Debra McConnell

Global Communications

(508) 390-2323

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Fashion Retail Discount/Variety Department Stores Manufacturing Textiles

MEDIA:

Logo
Logo